v3.22.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 305,896 $ 316,827
Marketable securities, at fair value 175,534 198,563
Accounts receivable, net 110,796 112,130
Inventories 23,840 23,395
Prepaid assets 14,341 12,354
Assets held for sale 0 10,050
Other current assets 20,693 8,189
Total current assets 651,100 681,508
Property and equipment (net of accumulated depreciation of $116,254 and $109,952, respectively) 108,942 109,465
Operating lease right-of-use assets 101,955 102,197
Intangible assets, net 433,835 442,325
Goodwill 527,115 527,115
Other assets 6,600 7,168
Total non-current assets 1,178,447 1,188,270
Total assets 1,829,547 1,869,778
Current liabilities    
Accounts payable 20,481 17,921
Accrued compensation 32,320 38,304
Accrued expenses and other liabilities 16,571 17,796
Current portion of equipment financing obligations 621 1,135
Current portion of operating lease liabilities 5,958 6,884
Pharma contract liabilities 6,119 5,192
Total current liabilities 82,070 87,232
Long-term liabilities    
Convertible senior notes, net 533,189 532,483
Operating lease liabilities 73,434 72,289
Deferred income tax liabilities, net 51,709 55,475
Other long-term liabilities 14,141 14,022
Total long-term liabilities 672,473 674,269
Total liabilities 754,543 761,501
Commitments and contingencies (Note 11)
Stockholders’ equity    
Common stock, $0.001 par value, (250,000,000 shares authorized; 124,722,215 and 124,107,500 shares issued and outstanding, respectively) 125 124
Additional paid-in capital 1,142,133 1,123,628
Accumulated other comprehensive loss (3,009) (638)
Accumulated deficit (64,245) (14,837)
Total stockholders’ equity 1,075,004 1,108,277
Total liabilities and stockholders’ equity $ 1,829,547 $ 1,869,778

Source